EuroAPI Logo

EuroAPI

Global manufacturer of APIs and CDMO services for human and animal health partners worldwide.

EAPI | PA

Overview

Corporate Details

ISIN(s):
FR0014008VX5 (+2 more)
LEI:
9695002FT7GGI3CKKJ14
Country:
France
Address:
15 RUE TRAVERSIERE, 75012 PARIS
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

EuroAPI is a leading global manufacturer of Active Pharmaceutical Ingredients (APIs). Spun off from Sanofi, the company leverages a unique European industrial network of six production sites to serve healthcare partners in over 80 countries. It offers one of the industry's largest portfolios, with approximately 200 APIs for human and animal health, and holds a leading position in small molecules. In addition to its extensive API catalog, EuroAPI provides Contract Development and Manufacturing Organization (CDMO) services for innovative companies, developing and producing more complex molecules. The company is focused on reliability, high-quality production standards, and regulatory compliance.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-23 17:45
Regulatory News Service
Avec Med4Cure, EUROAPI accélère l’innovation pharmaceutique au service de la so…
French 750.3 KB
2025-10-23 17:45
Regulatory News Service
With Med4Cure, EUROAPI accelerates pharmaceutical innovation at the service of …
English 748.2 KB
2025-09-30 17:45
Board/Management Information
Evolution de la composition du Conseil d’administration
French 535.7 KB
2025-09-30 17:45
Board/Management Information
Change in Board’s Composition
English 537.6 KB
2025-07-31 18:30
Report Publication Announcement
Mise à disposition du Rapport financier semestriel 2025
French 444.9 KB
2025-07-31 18:30
Report Publication Announcement
Availability of 2025 Half-Year Financial Report
English 442.4 KB
2025-06-30 17:58
M&A Activity
EUROAPI cède le site de Haverhill à Particle Dynamics dans le cadre du plan de …
French 531.0 KB
2025-06-30 17:58
M&A Activity
EUROAPI sells Haverhill site to Particle Dynamics as part of its FOCUS-27 trans…
English 704.7 KB
2025-06-17 17:02
Major Shareholding Notification
Franchissement de seuils
French 124.2 KB
2025-06-17 16:46
Major Shareholding Notification
Franchissement de seuils
French 104.6 KB
2025-06-04 17:45
Board/Management Information
Frédéric Robert appointed EUROAPI’s Chief Commercial Officer overseeing API Sol…
English 704.4 KB
2025-06-04 17:45
Board/Management Information
EUROAPI nomme Frédéric Robert au poste de Directeur commercial en charge des ac…
French 529.1 KB
2025-05-21 17:45
Post-Annual General Meeting Information
Assemblée Générale Mixte du 21 mai 2025
French 522.9 KB
2025-05-21 17:45
Post-Annual General Meeting Information
Combined General Meeting of May 21, 2025
English 722.2 KB
2025-04-29 17:40
Pre-Annual General Meeting Information
Assemblée Générale mixte du 21 mai 2025 - Modalités de mise à disposition ou de…
French 500.7 KB

Automate Your Workflow. Get a real-time feed of all EuroAPI filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for EuroAPI

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for EuroAPI via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Armata Pharmaceuticals, Inc. Logo
Developing bacteriophage therapeutics for antibiotic-resistant infections.
United States of America ARMP
AroCell AB Logo
Develops and markets diagnostic tests for monitoring cancer and bacterial diseases.
Sweden AROC
ArriVent BioPharma, Inc. Logo
A clinical-stage biopharma developing in-licensed oncology drugs for difficult-to-treat diseases.
United States of America AVBP
ARROWHEAD PHARMACEUTICALS, INC. Logo
Develops RNAi medicines to silence genes causing intractable cardiometabolic and pulmonary diseases.
United States of America ARWR
ARS Pharmaceuticals, Inc. Logo
Develops the first FDA-approved, needle-free epinephrine spray for severe allergic reactions.
United States of America SPRY
ARTELO BIOSCIENCES, INC. Logo
Develops lipid-signaling therapeutics for cancer, pain, anxiety, and depression.
United States of America ARTL
Artiva Biotherapeutics, Inc. Logo
Develops allogeneic, off-the-shelf NK cell therapies for cancer and autoimmune diseases.
United States of America ARTV
Ascelia Pharma Logo
Develops novel drugs for rare oncology, including an oral MRI contrast agent for cancer patients.
Sweden ACE
Ascendis Pharma A/S Logo
Biopharma using proprietary TransCon® tech to develop therapies for rare diseases & oncology.
United States of America ASND
ASCENTAGE PHARMA GROUP INTERNATIONAL Logo
Biopharma developing small-molecule drugs for cancer, HBV, and age-related diseases.
United States of America AAPG

Talk to a Data Expert

Have a question? We'll get back to you promptly.